foxo4-dri patent Research Peptide – 15mg The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs FOXO4 DRI 99% Purity, COA Included Glow Peptides FOX04 DRI (10mg) Nordsci FOXO4 DRI Chimera Peptides
Pay in 4 interest-free payments of $5.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





